← back to search

Siminder Atwal

Resolve Therapeutics (United States) · US
Area of research
Pulmonary and Respiratory Medicine · Genetics
Research interest
Research interests include Chronic Lymphocytic Leukemia Research, Lung Cancer Treatments and Mutations, Lymphoma Diagnosis and Treatment, and Lung Cancer Diagnosis and Treatment.
h-index
11
citations
1,162
works
32
NIH funding
—
primary concept
Medicine
email
✉ Find email ↗

Recent publications

Zanubrutinib for the treatment of relapsed or refractory mantle cell lymphoma
Blood Advances 2021cited by 98position: middledoi
Zanubrutinib for the treatment of patients with Waldenström macroglobulinemia: 3 years of follow-up
Blood 2020cited by 107position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Gavin Cull · Sir Charles Gairdner Hospital2 papers (2020–2021)Constantine S. Tam · Alfred University2 papers (2020–2021)David Simpson · The University of Melbourne2 papers (2020–2021)William Novotny · Addgene2 papers (2020–2021)Judith Trotman · Repatriation General Hospital2 papers (2020–2021)Stephen Opat · Monash Health2 papers (2020–2021)Javier Muñoz · Creighton University2 papers (2020–2021)Jane Huang · Los Angeles Medical Center2 papers (2020–2021)Rachel Wei · Amgen (United States)1 papers (2021–2021)Ziwen Tan · Jiangxi University of Finance and Economics1 papers (2020–2020)Alessandra Tedeschi · Centro de Investigación Biomédica en Red de Cáncer1 papers (2020–2020)David Gottlieb · The University of Sydney1 papers (2020–2020)Andrew W. Roberts · The University of Melbourne1 papers (2020–2020)James Hilger · Universidad San Carlos1 papers (2020–2020)Simon Rule · AstraZeneca (United Kingdom)1 papers (2021–2021)Tycel Phillips · Michigan Cancer Research Consortium1 papers (2021–2021)Paula Marlton · The University of Queensland1 papers (2020–2020)Won Seog Kim · McGill University1 papers (2021–2021)John F. Seymour · Peter MacCallum Cancer Centre1 papers (2020–2020)Michael Wang · University of Guelph1 papers (2021–2021)